Ullman’s Op-Ed on CBD Appears in Long Island Business News

January 29, 2020 | Compliance Investigations & White Collar | Cannabis

On January 29, 2020, Marc Ullman’s opinion piece, “FDA’s lack of CBD guidance is a disservice to Long Island firms,” appeared in Long Island Business News.

Marc notes that an exploding market for CBD products has created a conundrum for companies wishing to cash in. Either they obey FDA’s regulations and lose out, or they break the law and risk the consequences.

To read the story, click here.

Share this article:

Related News

Get legal updates and news delivered to your inbox